One ticker, one page: health score, red flags, fundamentals, who’s buying, cash & dilution, and the latest catalyst — every module built from SEC filings, ready to print or share.
start from a preset — you get the bundle, then edit it
or pick exactly what you want — 5 selected
These add one extra lookup each — still fine to combine.
Heavy modules — each one runs on its own. Checking one clears the rest, because it reads several filings live and would otherwise time the page out.
Your selection lives in the link, so a built report is shareable and bookmarkable. Educational information from public filings — not investment advice.
Assembling WNW’s research report…
Pulling SEC filings
Parsing XBRL fundamentals
Scoring quality, value & momentum
Checking who’s buying
Rendering
WNW Meiwu Technology Company Limited
Research report · from SEC EDGAR · close 2026-11-02
$1.95 -3.0%
mkt cap withheld
Close: REPORTED End-of-day closing price; as of 2026-11-02. No single source document identified.
Market cap: Source: withheld, because the newest filed share count (dei:EntityCommonStockSharesOutstanding) is as of 2025-12-31, 306 days before the 2026-11-02 close. Some issuers stop filing that figure; a count that old is not today's company.
Meiwu Technology Company Limited (WNW). Revenue is $7.1M (+4368.0% y/y) at a -263% net margin. It is not yet profitable. Our health score is C (64/100). 1 red flag on file. Smart money is buying (1 insider). It funds itself; low dilution risk.
Revenue and growth: REPORTED SEC XBRL companyfacts, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; as of FY ending 2025-12-31; Form 20-F 0001493152-26-017159, filed 2026-04-17.
Net margin: UNVALIDATED Net income over revenue, from SEC XBRL companyfacts; as of FY ending 2025-12-31. Method not verified against an independent source.
Net income: REPORTED SEC XBRL companyfacts, us-gaap:NetIncomeLoss; as of FY ending 2025-12-31; Form 20-F 0001493152-26-017159, filed 2026-04-17.
Health score: UNVALIDATED StockTools.ai health score, from SEC XBRL companyfacts and end-of-day prices; as of scores FY ending 2025-12-31; cash as of 2025-12-31; trend at close 2026-11-02. Method not verified against an independent source.
Insider counts: DERIVED SEC Form 4, open-market purchases (P) and sales (S); as of filed 2026-05-11 to 2026-05-11.
Periodic transaction reports filed under the STOCK Act; as of no report in the window read.
REPORTED SEC XBRL companyfacts, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; as of FY ending 2025-12-31; Form 20-F 0001493152-26-017159, filed 2026-04-17.
Net income
$-18.6M
REPORTED SEC XBRL companyfacts, us-gaap:NetIncomeLoss; as of FY ending 2025-12-31; Form 20-F 0001493152-26-017159, filed 2026-04-17.
Net margin
-262.5%
UNVALIDATED Net income over revenue, from SEC XBRL companyfacts; as of FY ending 2025-12-31. Method not verified against an independent source.
EPS (diluted)
$-0.82
REPORTED SEC XBRL companyfacts, us-gaap:EarningsPerShareDiluted; as of FY ending 2025-12-31; Form 20-F 0001493152-26-017159, filed 2026-04-17.
Piotroski F
4/9
UNVALIDATED Piotroski F-Score, computed from SEC XBRL companyfacts; as of FY ending 2025-12-31, against FY ending 2024-12-31.
An effective S-3 shelf with 2 prospectus filing(s) in 12 months — shares may be getting sold into the market.
REPORTED SEC EDGAR filing index, shelf registrations (S-3, F-3) and 424B prospectuses, F-3/A; as of shelf filed 2026-02-23, effective 2026-02-24.
who's buying
Insider buys / sells
1 / 1
DERIVED SEC Form 4, open-market purchases (P) and sales (S); as of filed 2026-05-11 to 2026-05-11.
Congress buys
0
DERIVED Periodic transaction reports filed under the STOCK Act; as of no report in the window read. No single source document identified; no as-of date carried.
13F fund holders
0
DERIVED SEC Form 13F-HR, the funds we track; as of no tracked fund reports a position. No single source document identified; no as-of date carried.
DERIVED SEC XBRL companyfacts, balance sheet, us-gaap:CashAndCashEquivalentsAtCarryingValue; as of 2025-12-31.
Operating cash flow
$9.0M
REPORTED SEC XBRL companyfacts, cash flow statement, us-gaap:NetCashProvidedByUsedInOperatingActivities; as of FY ending 2025-12-31.
Going concern
None
REPORTED SEC full-text search for "substantial doubt" in 10-K and 10-Q filings; as of filed 2025-07-31 to 2026-11-03.
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices. Each figure prints its own source and the date it is true as of beneath it, with REPORTED for a figure the source published and DERIVED or UNVALIDATED for our arithmetic; nothing is fabricated or predicted. Filings lag 40 to 90 days. Educational, not investment advice. Generated 2026-11-03 by stocktools.ai.
No single source document identified; no as-of date carried.
Fund holders: DERIVED SEC Form 13F-HR, the funds we track; as of no tracked fund reports a position. No single source document identified; no as-of date carried.
Cash need: DERIVED Operating cash flow and cash on hand, from SEC XBRL companyfacts; as of cash as of 2025-12-31; operating cash flow over FY ending 2025-12-31.
Method not verified against an independent source.
Altman Z
safe
UNVALIDATED Altman Z-Score, computed from SEC XBRL companyfacts; as of FY ending 2025-12-31, against FY ending 2024-12-31. Method not verified against an independent source.